Optimizing Treatment of Relapsing-Remitting Multiple Sclerosis with Oral Therapies

Drs Obeidat and Okai, 2 MS experts, discuss impact of relapsing-remitting multiple sclerosis (RRMS) on the quality of life of patients and caregivers.

Dr Okai explains why it is important to initiate MS treatment early and to stay compliant with the treatment.

Two MS experts discuss shared decision-making and other considerations in choosing MS treatment.

Dr Okai provides an overview of oral DMTs available to patients with RRMS.

MS experts highlight the value of monitoring and use of risk mitigation strategies when taking care of patients with MS.

Drs Obeidat and Okai discuss long-term data with oral DMTs that were recently presented at ACTRIMS 2022.

Two MS experts discuss how the field is benefiting from availability of real-world data, given the absence of head-to-head trials.

Annette Okai, MD, FAAN, discusses how she is utilizing the newer oral therapies and treatment advances in her practice.

Drs Okai and Obeidat share their excitement about an emerging new drug class for the treatment of MS.

Two MS experts discuss use and efficacy of vaccinations in patients with MS, especially in patients who are on oral DMTs.

Drs Obeidat and Okai share clinical pearls for physicians taking care of patients with MS.